Lite Strategy, Inc. Increase (Decrease) in Contract with Customer, Liability
Lite Strategy, Inc. (LITS) reported Increase (Decrease) in Contract with Customer, Liability of $0 for the 12-month period ending 2025-06-30, per its 10-K filed 2025-09-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2025-09-26
- Lite Strategy, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-06-30 was $0.00.
- Lite Strategy, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-03-31 was $0.00.
- Lite Strategy, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2024-12-31 was $0.00.
- Lite Strategy, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2024-09-30 was $0.00.
- Lite Strategy, Inc. increase (decrease) in contract with customer, liability for fiscal 2025 was $0.00.
- Lite Strategy, Inc. increase (decrease) in contract with customer, liability for fiscal 2024 was -$64.86M.
- Lite Strategy, Inc. increase (decrease) in contract with customer, liability for fiscal 2023 was -$30.58M, a 288.52% decline from fiscal 2022.
- Lite Strategy, Inc. increase (decrease) in contract with customer, liability for fiscal 2022 was $16.22M.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 3 month as first filed | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 6 month as first filed | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 9 month as first filed | Increase (Decrease) in Contract with Customer, Liability 12 month | Increase (Decrease) in Contract with Customer, Liability 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-26 | $0.00 derived: sum of 2 quarters · filed 2025-09-26 | $0.00 derived: sum of 3 quarters · filed 2025-09-26 | $0.00 10-K · filed 2025-09-26 | ||||
| 2025-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-13 | $0.00 derived: sum of 2 quarters · filed 2025-05-13 | $0.00 10-Q · filed 2025-05-13 | $0.00 derived: sum of 4 quarters · filed 2025-09-26 | ||||
| 2024-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-12 | $0.00 10-Q · filed 2025-02-12 | $0.00 derived: sum of 3 quarters · filed 2025-09-26 | $0.00 derived: sum of 4 quarters · filed 2025-09-26 | ||||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-09-26 | $0.00 derived: sum of 3 quarters · filed 2025-09-26 | $0.00 derived: sum of 4 quarters · filed 2025-09-26 | ||||
| 2024-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-26 | $0.00 derived: sum of 2 quarters · filed 2025-09-26 | $0.00 derived: sum of 3 quarters · filed 2025-09-26 | -$64.86M 10-K · filed 2025-09-26 | ||||
| 2024-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-13 | $0.00 derived: sum of 2 quarters · filed 2025-05-13 | -$64.86M 10-Q · filed 2025-05-13 | -$66.13M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-12 | -$64.86M 10-Q · filed 2025-02-12 | -$66.13M derived: sum of 3 quarters · filed 2025-02-12 | -$67.44M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-09-30 | -$64.86M 10-Q · filed 2024-11-12 | -$66.13M derived: sum of 2 quarters · filed 2024-11-12 | -$67.44M derived: sum of 3 quarters · filed 2024-11-12 | -$94.47M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | -$1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-19 | -$2.58M derived: sum of 2 quarters · filed 2024-09-19 | -$29.61M derived: sum of 3 quarters · filed 2024-09-19 | -$30.58M 10-K · filed 2024-09-19 | ||||
| 2023-03-31 | -$1.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-09 | -$28.34M derived: sum of 2 quarters · filed 2024-05-09 | -$29.32M 10-Q · filed 2024-05-09 | -$30.58M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | -$27.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-13 | -$28.00M 10-Q · filed 2024-02-13 | -$29.27M derived: sum of 3 quarters · filed 2024-02-13 | -$30.52M derived: sum of 4 quarters · filed 2024-02-13 | ||||
| 2022-09-30 | -$971.00K 10-Q · filed 2023-11-09 | -$2.24M derived: sum of 2 quarters · filed 2023-11-09 | -$3.48M derived: sum of 3 quarters · filed 2023-11-09 | -$5.17M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | -$1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-26 | -$2.51M derived: sum of 2 quarters · filed 2023-09-26 | -$4.20M derived: sum of 3 quarters · filed 2023-09-26 | $16.22M 10-K · filed 2023-09-26 | ||||
| 2022-03-31 | -$1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-11 | -$2.93M derived: sum of 2 quarters · filed 2023-05-11 | $17.49M 10-Q · filed 2023-05-11 | $8.51M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -$1.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-09 | $18.74M 10-Q · filed 2023-02-09 | $6.72M 10-Q · filed 2022-02-10 | $9.76M derived: sum of 3 quarters · filed 2023-02-09 | $7.66M derived: sum of 4 quarters · filed 2023-02-09 | |||
| 2021-09-30 | $20.42M 10-Q · filed 2022-11-14 | $14.79M 10-Q · filed 2021-11-10 | $11.44M derived: sum of 2 quarters · filed 2022-11-14 | $9.34M derived: sum of 3 quarters · filed 2022-11-14 | $6.91M derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | -$8.98M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-08 | -$11.08M derived: sum of 2 quarters · filed 2022-09-08 | -$13.51M derived: sum of 3 quarters · filed 2022-09-08 | -$4.43M 10-K · filed 2022-09-08 | $4.83M 10-K · filed 2021-09-02 | |||
| 2021-03-31 | -$2.10M 10-Q · filed 2021-05-06 | -$4.53M derived: sum of 2 quarters · filed 2022-05-23 | $4.55M 10-Q · filed 2022-05-23 | $7.38M 10-Q · filed 2021-05-06 | $72.36M derived: sum of 4 quarters · filed 2022-09-08 | |||
| 2020-12-31 | -$2.43M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2022-05-23 | -$3.90M 10-Q/A · filed 2022-05-23 | $2.33M 10-Q · filed 2021-02-04 | $74.46M derived: sum of 3 quarters · filed 2022-09-08 | $73.59M derived: sum of 4 quarters · filed 2022-09-08 | |||
| 2020-09-30 | -$1.47M 10-Q/A · filed 2022-05-23 | $1.34M 10-Q · filed 2020-11-10 | $76.89M derived: sum of 2 quarters · filed 2022-09-08 | $76.03M derived: sum of 3 quarters · filed 2022-09-08 | $75.28M derived: sum of 4 quarters · filed 2022-09-08 | |||
| 2020-06-30 | $78.36M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-08 | $77.49M derived: sum of 2 quarters · filed 2022-09-08 | $76.75M derived: sum of 3 quarters · filed 2022-09-08 | $75.88M 10-K · filed 2022-09-08 | $74.73M 10-K · filed 2020-09-09 | |||
| 2020-03-31 | -$869.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-06 | -$1.61M derived: sum of 2 quarters · filed 2021-05-06 | -$2.48M 10-Q · filed 2021-05-06 | -$3.12M derived: sum of 4 quarters · filed 2022-05-23 | ||||
| 2019-12-31 | -$742.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-04 | -$1.61M 10-Q · filed 2021-02-04 | -$2.25M derived: sum of 3 quarters · filed 2022-05-23 | -$2.98M derived: sum of 4 quarters · filed 2022-05-23 | ||||
| 2019-09-30 | -$868.00K 10-Q · filed 2020-11-10 | -$1.51M derived: sum of 2 quarters · filed 2022-05-23 | -$2.23M derived: sum of 3 quarters · filed 2022-05-23 | $6.17M derived: sum of 4 quarters · filed 2022-05-23 | ||||
| 2019-06-30 | -$645.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-05-23 | -$1.37M derived: sum of 2 quarters · filed 2022-05-23 | $7.03M derived: sum of 3 quarters · filed 2022-05-23 | $6.99M 10-K/A · filed 2022-05-23 | ||||
| 2019-03-31 | -$722.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-07 | $7.68M derived: sum of 2 quarters · filed 2020-05-07 | $7.63M 10-Q · filed 2020-05-07 | $7.58M derived: sum of 4 quarters · filed 2020-09-09 | ||||
| 2018-12-31 | $8.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-06 | $8.35M 10-Q · filed 2020-02-06 | $8.30M derived: sum of 3 quarters · filed 2020-09-09 | $8.25M derived: sum of 4 quarters · filed 2020-09-09 | ||||
| 2018-09-30 | -$48.00K 10-Q · filed 2019-11-07 | $48.00K 10-Q · filed 2018-11-08 | -$103.00K derived: sum of 2 quarters · filed 2020-09-09 | -$150.00K derived: sum of 3 quarters · filed 2020-09-09 | ||||
| 2018-06-30 | -$55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-09 | -$102.00K derived: sum of 2 quarters · filed 2020-09-09 | -$208.00K 10-K · filed 2020-09-09 | |||||
| 2018-03-31 | -$47.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-09 | -$153.00K 10-Q · filed 2019-05-09 | ||||||
| 2017-12-31 | -$106.00K 10-Q · filed 2019-02-07 | |||||||
| 2017-06-30 | $996.00K 10-K · filed 2019-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |